title: Effect of viral infection on T-cell apoptosis in allograft recipients.
authors.affiliation: Transplantation Institute, Warsaw, Poland.
authors.forename: Z
authors.initials: Z
authors.lastname: Rancewicz
authors.forename: M
authors.initials: M
authors.lastname: Kasprzycka
authors.forename: R
authors.initials: R
authors.lastname: Zagozdzon
authors.forename: P
authors.initials: P
authors.lastname: Wierzbicki
authors.forename: M
authors.initials: M
authors.lastname: Durlik
authors.forename: J
authors.initials: J
authors.lastname: Juskowa
authors.forename: A
authors.initials: A
authors.lastname: Górski
authors.forename: L
authors.initials: L
authors.lastname: Paczek
mesh_terms: D017209:Apoptosis / Q000276:immunology*; D003586:Cytomegalovirus Infections / Q000276:immunology*; D004359:Drug Therapy, Combination; D020031:Epstein-Barr Virus Infections / Q000276:immunology*; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology*; D008213:Lymphocyte Activation / Q000187:drug effects; D008297:Male; D016853:Muromonab-CD3 / Q000494:pharmacology; D011183:Postoperative Complications / Q000276:immunology / Q000821:virology*; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology*; D014184:Transplantation, Homologous
chemical_list: D007166:Immunosuppressive Agents; D016853:Muromonab-CD3